Clinical Trial Update: Post-Market Study to Assess iTind Safety in Comparison to UroLift [NA]

View source ↗

Summary

A post-market study sponsored by Olympus Corporation of the Americas is recruiting to compare the safety of the iTind device with UroLift in patients with Benig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• UroLift System
• iTind

Snippet

Sponsor: Olympus Corporation of the Americas | Conditions: Benign Prostatic Hyperplasia (BPH) | NA | Status: RECRUITING